243 related articles for article (PubMed ID: 22568880)
21. Significant simultaneous changes in serum CA19-9 and CA125 due to prolonged torsion of mature cystic teratoma of the ovary.
Suh DS; Moon SH; Kim SC; Joo JK; Park WY; Kim KH
World J Surg Oncol; 2014 Nov; 12():353. PubMed ID: 25416055
[TBL] [Abstract][Full Text] [Related]
22. Potential markers that complement expression of CA125 in epithelial ovarian cancer.
Rosen DG; Wang L; Atkinson JN; Yu Y; Lu KH; Diamandis EP; Hellstrom I; Mok SC; Liu J; Bast RC
Gynecol Oncol; 2005 Nov; 99(2):267-77. PubMed ID: 16061277
[TBL] [Abstract][Full Text] [Related]
23. [Clinical analysis of 44 cases with malignant transformation of ovarian mature cystic teratoma].
An JS; Wu LY; Li XG; Zhang R; Song Y; Ma SK; Liu LY; Hong WJ
Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):123-8. PubMed ID: 23544494
[TBL] [Abstract][Full Text] [Related]
24. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561
[TBL] [Abstract][Full Text] [Related]
25. Clinical evaluation of mature teratomas containing malignant elements.
Hirai K; Ishiko O; Itoh F; Nakagawa E; Kanaoka Y; Sumi T; Ogita S
Oncol Rep; 2000; 7(3):655-7. PubMed ID: 10767385
[TBL] [Abstract][Full Text] [Related]
26. Serum tumour markers in patients with chronic kidney disease.
Xiaofang Y; Yue Z; Xialian X; Zhibin Y
Scand J Clin Lab Invest; 2007; 67(6):661-7. PubMed ID: 17852811
[TBL] [Abstract][Full Text] [Related]
27. Elevated CA 19-9 levels in mature cystic teratoma of the ovary.
Kyung MS; Choi JS; Hong SH; Kim HS
Int J Biol Markers; 2009; 24(1):52-6. PubMed ID: 19404923
[TBL] [Abstract][Full Text] [Related]
28. Can malignant transformation in mature cystic teratoma be preoperatively predicted?
Futagami M; Yokoyama Y; Mizukami H; Shigeto T; Mizunuma H
Eur J Gynaecol Oncol; 2012; 33(6):662-5. PubMed ID: 23327068
[TBL] [Abstract][Full Text] [Related]
29. Ovarian strumal carcinoid with markedly high serum levels of tumor markers.
Takemori M; Nishimura R; Sugimura K; Obayashi C; Yasuda D
Gynecol Oncol; 1995 Aug; 58(2):266-9. PubMed ID: 7622118
[TBL] [Abstract][Full Text] [Related]
30. Do high levels of CA 19-9 in women with mature cystic teratomas of the ovary warrant further evaluation?
Ugur MG; Ozturk E; Balat O; Dikensoy E; Teke S; Aydin A
Eur J Gynaecol Oncol; 2012; 33(2):207-10. PubMed ID: 22611965
[TBL] [Abstract][Full Text] [Related]
31. [Significance of CA19-9 in mature cystic teratoma].
Ito K
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):524-8. PubMed ID: 1619311
[TBL] [Abstract][Full Text] [Related]
32. The prognostic value of pre-operative serum tetranectin, CA-125 and a combined index in women with primary ovarian cancer.
Høgdall CK; Nørgaard-Pedersen B; Mogensen O
Anticancer Res; 2002; 22(3):1765-8. PubMed ID: 12168866
[TBL] [Abstract][Full Text] [Related]
33. Clinical evaluation of serum and immunohistochemical expression of SCC and CA19-9 in radiation therapy for cervical cancer.
Abe A; Nakano T; Morita S; Oka K
Anticancer Res; 1999; 19(1B):829-36. PubMed ID: 10216501
[TBL] [Abstract][Full Text] [Related]
34. Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer.
Zhang W; Wang L; Xin Z
Medicine (Baltimore); 2018 Apr; 97(16):e0358. PubMed ID: 29668586
[TBL] [Abstract][Full Text] [Related]
35. Massive peritoneal fluid and markedly elevated serum CA125 and CA19-9 levels associated with an ovarian endometrioma.
Park BJ; Kim TE; Kim YW
J Obstet Gynaecol Res; 2009 Oct; 35(5):935-9. PubMed ID: 20149044
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward?
Azzam AZ; Hashad DI; Kamel NA
Arch Gynecol Obstet; 2013 Jul; 288(1):167-72. PubMed ID: 23361457
[TBL] [Abstract][Full Text] [Related]
37. [Measurement of serum human epididymis secretory protein 4 combined with CA125 assay in differential diagnosis of endometriosis cyst and ovarian benign and malignant tumors].
Liu YN; Ye X; Cheng HY; Cheng YX; Fu TY; Chen J; Chang XH; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2010 May; 45(5):363-6. PubMed ID: 20646446
[TBL] [Abstract][Full Text] [Related]
38. CA19-9 may have clinical significance in mature cystic teratomas of the ovary.
Dede M; Gungor S; Yenen MC; Alanbay I; Duru NK; Haşimi A
Int J Gynecol Cancer; 2006; 16(1):189-93. PubMed ID: 16445632
[TBL] [Abstract][Full Text] [Related]
39. Mature Cystic Teratoma of Ovary with Abnormally High Levels of Ca19-9: A Case Report.
Sampaio J; Sarmento-Gonçalves I; Barros JM; Felix J; Tiago-Silva P
Rev Bras Ginecol Obstet; 2016 Jul; 38(7):365-7. PubMed ID: 27434195
[TBL] [Abstract][Full Text] [Related]
40. Immunohistological analysis of stress-induced phosphoprotein 1 in ovarian cancer patients with low serum cancer antigen 125 levels.
Chao A; Lee LY; Hsueh C; Lin CY; Tsai CL; Chao AS; Lin CT; Chou HH; Chang TC; Wang TH
Taiwan J Obstet Gynecol; 2013 Jun; 52(2):185-91. PubMed ID: 23915849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]